Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA29	XELJANZ	B	Tofacitinib - 5mg	5mg	Tablet	80,685,473 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	606,649 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	952,208 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	952,208 L.L
G04CA01	XATRAL XL	B	Alfuzosin HCl - 10mg	10mg	Tablet, prolonged release	1,061,636 L.L
B01AF01	XARELTO	B	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,588,892 L.L
B01AF01	XARELTO	B	Rivaroxaban - 20mg	20mg	Tablet, film coated	4,440,862 L.L
B01AF01	XARELTO	B	Rivaroxaban - 15mg	15mg	Tablet, film coated	4,440,862 L.L
B01AF01	XARELTO	B	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	4,045,168 L.L
N05BA12	XANAX	B	Alprazolam - 0.5mg	0.5mg	Tablet	477,064 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	L.L
L01ED01	XALKORI	B	Crizotinib - 200mg	200mg	Capsule	347,644,061 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	347,644,061 L.L
N05AX12	XALIPRO	G	Aripiprazole - 5mg	5mg	Tablet	1,746,995 L.L
N05AX12	XALIPRO	G	Aripiprazole - 15mg	15mg	Tablet	2,418,917 L.L
N05AX12	XALIPRO	G	Aripiprazole - 10mg	10mg	Tablet	2,123,271 L.L
S01EE01	XALATAN	B	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	704,173 L.L
S01ED51	XALACOM	B	Timolol (maleate) - 6.8mg/ml, Latanoprost - 50μg/ml		Drops solution	510,660 L.L
J01DD08	WINEX	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,307,559 L.L
J01DD08	WINEX	G	Cefixime (trihydrate) - 200mg	200mg	Capsule	731,050 L.L
J01DD08	WINEX	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Suspension	700,142 L.L
B02BD06	WILATE 500	BioHuman	Von Willebrand Factor - 500IU, Blood Coagulation Factor VIII - 500IU		Injectable powder for solution+diluent	32,399,164 L.L
L01XX74	WELIREG	B	Belzutifan - 40mg	40mg	Tablet, film coated	1,550,772,301 L.L
S02DC	WAXSOL	B	Docusate sodium - 0.5%	0.5%	Drops solution	157,230 L.L
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,103,295 L.L
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,339,811 L.L
V07AB01	WATER FOR INJECTION	G	Water for Injection -		Water for injection, irrigation	4,365,735 L.L
V07AB01	WATER FOR INJECTION	G	Water for Injection -		Water for injection, irrigation	2,032,899 L.L
V07AB01	WATER FOR INJECTION	G	Water for Injection -		Water for injection, irrigation	2,706,319 L.L
S01EE06	VYZULTA	B	Latanoprostene bunod - 0.024%	0.024%	Solution	1,948,572 L.L

...

187